A Preliminary Study Revealing a New Association in Patients Undergoing Maintenance Hemodialysis: Manganism Symptoms and T1 Hyperintense Changes in the Basal Ganglia

References

1. ↵
   Krieger S, Jauss M, Jansen O, et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J Hepatol 1997;27:121–26

   CrossRefPubMedWeb of Science
2. Raskin NH, Price JB, Fishman RA. Portosystemic encephalopathy due to congenital intrahepatic shunts. N Engl J Med 1964;270:225–29

   PubMedWeb of Science
3. Akahoshi T, Nishizaki T, Wakasugi K, et al. Portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt: three cases and literature review. Hepatogastroenterology 2000;47:1113–16

   PubMed
4. Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991;179:551–55

   PubMedWeb of Science
5. Maeda H, Sato M, Yoshikawa A, et al. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 1997;39:546–50

   CrossRefPubMedWeb of Science
6. ↵
   da Rocha AJ, Braga FT, da Silva CJ, et al. Reversal of parkinsonism and portosystemic encephalopathy following embolization of a congenital intrahepatic venous shunt: brain MR imaging and 1H spectroscopic findings. AJNR Am J Neuroradiol 2004;25:1247–50

   Abstract/FREE Full Text
7. ↵
   Dietemann JL, Reimund JM, Diniz RL, et al. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on long-term parenteral nutrition. Neuroradiology 1998;40:793–96

   CrossRefPubMed
8. ↵
   Nelson K, Golnick J, Korn T, et al. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993;50:510–13

   PubMedWeb of Science
9. ↵
   Ono K, Komai K, Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci 2002;199:93–96

   CrossRefPubMedWeb of Science
10. ↵
    Sadek AH, Rauch R, Schulz PE. Parkinsonism due to manganism in a welder. Int J Toxicol 2003;22:393–401

    Abstract/FREE Full Text
11. ↵
    Kim Y, Kim JW, Ito K, et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999;20:249–52

    PubMedWeb of Science
12. Newland MC, Ceckler TL, Kordower JH, et al. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989;106:251–58

    CrossRefPubMedWeb of Science
13. Shinotoh H, Snow BJ, Hewitt KA, et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995;45:1199–204

    Abstract/FREE Full Text
14. Eriksson H, Tedroff J, Thuomas KA, et al. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 1992;66:403–07

    CrossRefPubMedWeb of Science
15. ↵
    Josephs KA, Ahlskog JE, Klos KJ, et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005;64:2033–39

    Abstract/FREE Full Text
16. Bowler RM, Koller W, Schulz PE. Parkinsonism due to manganism in a welder: neurological and neuropsychological sequelae. Neurotoxicology 2006;27:327–32

    CrossRefPubMedWeb of Science
17. ↵
    Kenangil G, Ertan S, Sayilir I, et al. Progressive motor syndrome in a welder with pallidal T1 hyperintensity on MRI: a two-year follow-up. Mov Disord 2006;21:2197–200

    CrossRefPubMed
18. Dorman DC, Struve MF, Wong BA, et al. Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation. Toxicol Sci 2006;92:219–27

    Abstract/FREE Full Text
19. ↵
    Fitsanakis VA, Zhang N, Avison MJ, et al. The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology 2006;27:798–806

    CrossRefPubMed
20. McKinney AM, Filice RW, Teksam M, et al. Diffusion abnormalities of the globi pallidi in manganese neurotoxicity. Neuroradiology 2004;46:291–95

    CrossRefPubMedWeb of Science
21. ↵
    Solomou E, Velissaris D, Polychronopoulos P, et al. Quantitative evaluation of magnetic resonance imaging (MRI) abnormalities in subclinical hepatic encephalopathy. Hepatogastroenterology 2005;52:203–07

    PubMed
22. ↵
    Lee EJ, Choi JY, Lee SH, et al. Hemichorea-hemiballism in primary diabetic patients: MR correlation. J Comput Assist Tomogr 2002;26:905–11

    CrossRefPubMed
23. Nakajo M, Onohara S, Shinmura K, et al. Computed tomography and magnetic resonance imaging findings of brain damage by hanging. J Comput Assist Tomogr 2003;27:896–900

    CrossRefPubMed
24. Terada H, Barkovich AJ, Edwards MS, et al. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996;17:755–60

    Abstract
25. ↵
    Dell LA, Brown MS, Orrison WW. Physiologic intracranial calcifications with hyperintensity on MR imaging. AJNR Am J Neuroradiol 1988;9:1145–48

    Abstract/FREE Full Text
26. Mochizuki H, Kamakura K, Masaki T, et al. Atypical MRI features of Wilson's disease: high signal in globus pallidus on T1-weighted images. Neuroradiology 1997;39:171–74

    CrossRefPubMedWeb of Science
27. ↵
    Govaert P, Lequin M, Swarte R, et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 2003;112:1256–63

    Abstract/FREE Full Text
28. ↵
    Huang CC, Chu NS, Lu CS, et al. Chronic manganese intoxication. Arch Neurol 1989;46:1104–06

    CrossRefPubMedWeb of Science
29. Mena I, Marin O, Fuenzalida S, et al. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967;17:128–36

    FREE Full Text
30. ↵
    Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974;30:59–64

    CrossRefPubMedWeb of Science
31. ↵
    Abdel-Naby S, Hassanein M. Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychiatry 1965;28:282–88

    PubMed
32. ↵
    Hosokawa S, Oyamaguchi A, Yoshida O. Trace elements and complications in patients undergoing chronic hemodialysis. Nephron 1990;55:375–79

    PubMed
33. ↵
    Taylor PA, Price JDE. Acute manganese intoxication and pancreatitis in a patient treated with a contaminated dialysate. CMAJ 1982;126:503–05

    PubMed
34. ↵
    Heilbronn E, Eriksson H. Implications of manganese in diseases, especially central nervous system disorders. In: Yasui M, Strong MJ, Ota K, et al, eds. Mineral and Metal Neurotoxicology. Boca Raton, Fla: CRC;1997 :311–17
35. ↵
    Scheuhammer AM, Cherian MG. The distribution and excretion of manganese: the effects of manganese dose, L-dopa, and pretreatment with zinc. Toxicol Appl Pharmacol 1982;65:203–13

    CrossRefPubMed
36. ↵
    Papavasiliou PS, Miller ST, Cotzias GC. Role of liver in regulating distribution and excretion of manganese. Am J Physiol 1966;211:211–16

    FREE Full Text
37. ↵
    Ohtake T, Negishi K, Okamoto K, et al. Manganese-induced parkinsonism in a patient undergoing maintenance hemodialysis. Am J Kidney Dis 2005;46:749–53

    CrossRefPubMed
38. ↵
    Wang HC, Cheng SJ. The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients. J Neurol 2003;250:948–55

    CrossRefPubMedWeb of Science
39. ↵
    Agildere AM, Kurt A, Yildirim T, et al. MRI of neurologic complications in end-stage renal failure patients on hemodialysis: pictorial review. Eur Radiol 2001;11:1063–69

    CrossRefPubMedWeb of Science
40. ↵
    Tarhan NC, Agildere AM, Benli US, et al. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol 2004;182:809–16

    PubMedWeb of Science
41. ↵
    Gidden H, Holland FF, Klein K. Trace metals protein binding in normal and dialyzed uremic serum. Trans Am Soc Artif Intern Organs 1980;26:133–38

    PubMed
42. ↵
    Wang C, Gordon PB, Hustvedt SO, et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol 1997;38(4 pt 2):665–76
43. ↵
    Davidsson L, Cederblad A, Lonnerdal B, et al. Manganese retention in man: a method for estimating manganese absorption in man. Am J Clin Nutr 1989;49:170–79

    Abstract/FREE Full Text
44. ↵
    Greenberg DM, Campbell WW. Studies in mineral metabolism with the aid of induced radioactive isotopes: IV-manganese. Proc Natl Acad Sci U S A 1940;26:448–52

    FREE Full Text
45. ↵
    Schabowski J, Ksiazek A, Paprzycki P, et al. Ferrum, copper, zinc and manganese in tissues of patients treated with long-standing hemodialysis programme. Ann Univ Mariae Curie Sklodowska [Med] 1994;49:61–66

    PubMed
46. ↵
    Keen CL, Lönnerdal B, Hurley LS. Manganese. In: Frieden E, ed. Biochemistry of the Essential Ultra-Trace Elements. New York: Plenum;1984:89–132
47. ↵
    Aschner M, Gannon M, Kimelberg HK. Manganese uptake and efflux in cultured rat astrocytes. J Neurochem 1992;58:730–35

    CrossRefPubMedWeb of Science
48. ↵
    Tholey G, Ledig M, Mandel P, et al. Concentrations of physiologically important metal ions in glial cells cultured from chick cerebral cortex. Neurochem Res 1988;13:45–50

    CrossRefPubMedWeb of Science
49. ↵
    Wedler FC, Ley BW, Grippo AA. Manganese (II) dynamics and distribution in glial cells cultured from chick cerebral cortex. Neurochem Res 1989;14:1129–35

    CrossRefPubMedWeb of Science
50. ↵
    Chu NS, Hochberg FH, Caine DB, et al. Neurotoxicology. Hong Kong: Marcel Dekker;1995 :91–104
51. ↵
    Roels H, Lauwerys R, Buchet JP, et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med 1987;11:307–27

    PubMedWeb of Science